- Home
- IMNN vs FEAM Comparison
IMNN vs FEAM Comparison
Compare IMNN & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- FEAM
- Stock Information
- Founded
- IMNN 1982
- FEAM 2016
- Country
- IMNN United States
- FEAM United States
- Employees
- IMNN N/A
- FEAM N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- FEAM Major Chemicals
- Sector
- IMNN Health Care
- FEAM Industrials
- Exchange
- IMNN Nasdaq
- FEAM Nasdaq
- Market Cap
- IMNN 12.1M
- FEAM 12.8M
- IPO Year
- IMNN 1985
- FEAM N/A
- Fundamental
- Price
- IMNN $1.46
- FEAM $4.30
- Analyst Decision
- IMNN Buy
- FEAM Strong Buy
- Analyst Count
- IMNN 2
- FEAM 2
- Target Price
- IMNN $14.00
- FEAM $121.00
- AVG Volume (30 Days)
- IMNN 31.5M
- FEAM 8.6K
- Earning Date
- IMNN 05-12-2025
- FEAM 05-15-2025
- Dividend Yield
- IMNN N/A
- FEAM N/A
- EPS Growth
- IMNN N/A
- FEAM N/A
- EPS
- IMNN N/A
- FEAM N/A
- Revenue
- IMNN N/A
- FEAM N/A
- Revenue This Year
- IMNN N/A
- FEAM N/A
- Revenue Next Year
- IMNN N/A
- FEAM N/A
- P/E Ratio
- IMNN N/A
- FEAM N/A
- Revenue Growth
- IMNN N/A
- FEAM N/A
- 52 Week Low
- IMNN $0.37
- FEAM $2.82
- 52 Week High
- IMNN $3.65
- FEAM $37.03
- Technical
- Relative Strength Index (RSI)
- IMNN 52.73
- FEAM 47.84
- Support Level
- IMNN $0.85
- FEAM $4.04
- Resistance Level
- IMNN $3.16
- FEAM $4.35
- Average True Range (ATR)
- IMNN 0.52
- FEAM 0.30
- MACD
- IMNN 0.03
- FEAM -0.01
- Stochastic Oscillator
- IMNN 39.07
- FEAM 28.87
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.